Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Three-Dimensional Printing: A Catalyst for a Changing Orthopaedic Landscape.

PMID: 32224627 · 2020

J, o, n, a, t, h, a, n, , M, i, n, t, o, ;, , X, u, a, n, , Z, h, o, u, ;, , J, e, n, n, a, , O, s, b, o, r, n, ;, , L, i, j, i, e, , G, r, a, c, e, , Z, h, a, n, g, ;, , K, a, u, s, i, k, , S, a, r, k, a, r, ;, , R, a, j, , D, , R, a, o

RevistaJBJS reviews
Año2020
PMID32224627

Resumen

Three-dimensional (3D) printing is an emerging tool in provider and patient education, surgical planning, and the design and implementation of medical devices and implants. Recent decreases in the cost of 3D printers along with advances in and cost reduction of printable materials have elevated 3D printing within the medical device industry. The advantages of 3D printing over traditional means of implant manufacturing lie in its ability to use a wide array of materials, its fine control of the m

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑